doi:10.3969/j.issn.1673-8640.2020.08.025

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 9

[1]	王军,张艺,朱晓晖,等. 南通市某社区中老年脑血管病人群发病危险因素[J]. 中国老年学杂志,2015,35(15):4329-4331.
[2]	ARBOIX A,ALIO J. Acute cardioembolic cerebral infarction:answers to clinical questions[J]. Curr Cardiol Rev,2012,8(1):54-67.
[3]	赵旭,王鹏,李荣,等. 急性脑梗死患者脑动脉狭窄与炎性因子的相关性研究[J]. 中国实用神经疾病杂志,2017,20(1):39-41.
[4]	各类脑血管疾病诊断要点[J]. 中华神经科杂志,1996,42(6): 60-61.
[5]	史光东,罗继琼,冉瑞明,等. 脂联素、IL-6与老年脑梗死患者颈动脉中膜厚度的相关性[J]. 贵阳医学院学报,2014,39(1):74-76.
[6]	李建英,杨春水,杨志刚,等. 急性脑梗死患者多项血清炎性因子及血流动力学指标研究[J]. 海南医学院学报,2012,18(11):1571-1573.
[7]	张丽雅. 急性脑梗死患者脑动脉狭窄与炎性因子的相关性分析[J]. 实用医院临床杂志,2017,14(2):67-69.
[8]	LEHOTSKÝ J,TOTHOVÁ B,KOVALSKÁ M,et al. Role of homocysteine in the ischemic stroke and development of ischemic tolerance[J]. Front Neurosci,2016,10:538.
[9]	王渝,张哲成,朱炬,等. 脑梗死患者同型半胱氨酸与颈动脉内膜中层厚度的关系[J]. 天津医药,2014,42(9):899-902.

组别	例数	CRP/（mg/L）	TNF-α/（pg/mL）	IL-6/（pg/mL）	Hcy/（μmol/L）	IMT/mm
狭窄Ⅰ级组	28	74.35±15.30	65.47±15.06	92.05±23.61	25.21±5.20	0.88±0.27
狭窄Ⅱ级组	46	86.98±22.45^*	90.59±16.07^*	109.90±25.54^*	38.95±7.72^*	1.15±0.32^*
狭窄Ⅲ级组	32	106.32±23.79^*#	110.20±22.60^*#	135.40±24.86^*#	50.58±11.91^*#	1.48±0.43^*#
F值		17.458	45.906	23.317	63.403	22.996
P值		<0.05	<0.05	<0.05	<0.05	<0.05

组别	例数	CRP/（mg/L）	TNF-α/（pg/mL）	IL-6/（pg/mL）	Hcy/（μmol/L）	IMT/mm
狭窄Ⅰ级组	28	74.35±15.30	65.47±15.06	92.05±23.61	25.21±5.20	0.88±0.27
狭窄Ⅱ级组	46	86.98±22.45^*	90.59±16.07^*	109.90±25.54^*	38.95±7.72^*	1.15±0.32^*
狭窄Ⅲ级组	32	106.32±23.79^*#	110.20±22.60^*#	135.40±24.86^*#	50.58±11.91^*#	1.48±0.43^*#
F值		17.458	45.906	23.317	63.403	22.996
P值		<0.05	<0.05	<0.05	<0.05	<0.05

组别	例数	CRP/（mg/L）	TNF-α/（pg/mL）	IL-6/（pg/mL）	Hcy/（μmol/L）
内膜正常组	39	73.72±14.66	73.51±15.45	90.62±22.60	29.17±7.08
内膜增厚组	43	92.77±23.12^*	92.44±22.02^*	116.07±20.86^*	40.69±10.45^*
斑块形成组	24	109.20±23.05^*#	111.89±22.55^*#	143.35±23.43^*#	51.20±12.27^*#
F值		23.419	27.992	43.061	38.606
P值		<0.05	<0.05	<0.05	<0.05

组别	例数	CRP/（mg/L）	TNF-α/（pg/mL）	IL-6/（pg/mL）	Hcy/（μmol/L）
内膜正常组	39	73.72±14.66	73.51±15.45	90.62±22.60	29.17±7.08
内膜增厚组	43	92.77±23.12^*	92.44±22.02^*	116.07±20.86^*	40.69±10.45^*
斑块形成组	24	109.20±23.05^*#	111.89±22.55^*#	143.35±23.43^*#	51.20±12.27^*#
F值		23.419	27.992	43.061	38.606
P值		<0.05	<0.05	<0.05	<0.05

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 9

Related Articles 15

Recommended Articles

Metrics